« Back to Record
De Greve, J., Berchem, G., Colinet, B., Galdermans, D., Bosquée, L., Vermeij, J., Dewaele, A., Geers, C., Schallier, D., Teugels, E., Van Meerbeeck, J. P. A. M. J., Vansteenkiste, J., Decoster, L., Meert, A.-P., Vuylsteke, P., Focan, C., Canon, J.-L., & Humblet, Y. (2016). Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT). PloS one, 11(3), e0147599. doi:10.1371/journal.pone.0147599
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/259004



